Name: UMIN ID:
Unique ID issued by UMIN | C000000020 |
---|---|
Receipt number | R000000028 |
Scientific Title | Study of fluorouracil, epirubicin and cyclophosphamide followed by docetaxel as preoperative chemotherapy in primary breast cancer (JBCRG-02) |
Date of disclosure of the study information | 2005/07/05 |
Last modified on | 2019/11/21 15:58:37 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2005/07/05 15:43:07 | ||
2 | Update | 2005/08/17 09:37:34 | Public title Public title Acronym Acronym |
|
3 | Update | 2005/08/17 09:42:37 | Interventions/Control_1 Interventions/Control_1 |
|
4 | Update | 2005/10/12 11:43:50 | Division name Division name Address Address Institute Institute |
|
5 | Update | 2006/01/18 11:02:03 | Acronym |
|
6 | Update | 2006/01/30 18:00:57 | Address Organization Organization |
|
7 | Update | 2006/08/18 16:21:38 | Organization Address Address TEL |
|
8 | Update | 2007/02/02 16:09:32 | Other related information Other related information |
|
9 | Update | 2007/06/26 10:57:58 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information Other related information |
|
10 | Update | 2008/06/19 16:07:20 | UMIN ID2 |
|
11 | Update | 2008/06/23 10:56:11 | Address Address TEL Address Address TEL |
|
12 | Update | 2010/07/05 15:54:55 | Recruitment status |
|
13 | Update | 2011/11/15 15:39:49 | Publication of results Other related information Other related information |
|
14 | Update | 2013/06/17 16:07:44 | Acronym Acronym |
|
15 | Update | 2016/07/05 11:38:07 | Email Last name of contact person Last name of contact person Address Address TEL Address Address TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
16 | Update | 2018/08/23 17:28:57 | Acronym |
|
17 | Update | 2018/08/24 10:01:32 | UMIN ID1 UMIN ID2 |
|
18 | Update | 2019/11/21 15:58:37 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Address Organization Organization Address Address Tel |